Lijie Xing
- Oncology top 10%
- Hematology top 2%
- Molecular Biology
- Immunology
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Kenneth C. AndersonYu‐Tzu TaiShih‐Feng ChoLiang LinTengteng YuKenneth WenNikhil C. MunshiPhillip A. Hsieh
- Topics
- Multiple Myeloma Research and Treatments (27 papers)CAR-T cell therapy research (14 papers)Protein Degradation and Inhibitors (11 papers)
- Cited by
- HematologyOncologyImmunology
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Lijie Xing
44 papers receiving 665 citations
Peers
Comparison fields: 5 of 63
- Oncology 393
- Hematology 364
- Molecular Biology 336
- Immunology 176
- Radiology, Nuclear Medicine and Imaging 136
Countries citing papers authored by Lijie Xing
This map shows the geographic impact of Lijie Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie Xing more than expected).
Fields of papers citing papers by Lijie Xing
This network shows the impact of papers produced by Lijie Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie Xing. The network helps show where Lijie Xing may publish in the future.
Co-authorship network of co-authors of Lijie Xing
This figure shows the co-authorship network connecting the top 25 collaborators of Lijie Xing. A scholar is included among the top collaborators of Lijie Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie Xing. Lijie Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 22 | |
| 13 | 1 | |
| 14 | 64 | |
| 15 | 68 | |
| 16 | 50 | |
| 17 | 66 | |
| 18 | 65 | |
| 19 | 23 | |
| 20 | 6 |
About Lijie Xing
Lijie Xing is a scholar working on Hematology, Oncology and Immunology, having authored 49 papers that have together received 669 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (27 papers), CAR-T cell therapy research (14 papers) and Protein Degradation and Inhibitors (11 papers). The work is most often cited by research in Hematology (364 citations), Oncology (393 citations) and Immunology (176 citations). Lijie Xing has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Kenneth C. Anderson, Yu‐Tzu Tai, Shih‐Feng Cho, Liang Lin, Tengteng Yu, Kenneth Wen, Nikhil C. Munshi, Phillip A. Hsieh, Yuyin Li and Jiye Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.